New York, NYNCT06662448Now EnrollingIRB Ready

Optic Neuropathy Clinical Trial in New York, NY

Access cutting-edge optic neuropathy treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by NYU Langone Health

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access optic neuropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related optic neuropathy treatment provided free

Apply for This New York Location

Check if you qualify for this optic neuropathy clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Optic Neuropathy Study in New York

The purpose of this study is to test the efficacy and feasibility of an intervention protocol for home-based repetitive transorbital alternating current stimulation (rtACS) for the treatment of visual impairment in people with optic neuropathy. The primary aims are to evaluate the effectiveness of home-based rtACS to ameliorate the progressive effects of vision loss functionally in the eye and the visual pathway, and in regard to people's independence (i.e., functional ability).

Sponsor: NYU Langone Health

Who Can Participate

Inclusion Criteria

Age equal to or over 18 years old
Must have a permanent residence
Diagnosis of optic neuropathy
VF defects present in at least one eye (MD ≤ -3.00 dB) FL, FP, FN \<33%
Visual Field Index (VFI) 10-90%
Clear optical apparatus
Best-corrected VA of 20/400 or better in at least one eye
Commitment to comply with study procedures: 8-week period of intervention sessions (30 sessions every other day), baseline visit, post-intervention visit, and 2 follow-up visits (2 days per visit).
A subject deemed incapable of performing the study intervention independently due to visual impairment or any other condition that may prevent them from performing the intervention accurately require a family member or caregiver to assist in performing the intervention.

Exclusion Criteria

High intraocular pressure (over 27 mmHg)
End-stage organ disease or medical condition with subsequent vision loss (e.g., diabetes, stroke)
Advanced or unstable retinal diseases
Pathological nystagmus
Acute conjunctivitis
Photosensitivity to flickering lights
Non-ocular/ocular surgery within the previous 2 months to enrollment date
Electric or electronic implants (e.g., cardiac pacemaker)
Metallic artifacts/implants in head and/or torso (titanium screw and dental implants are allowed)
Diagnosed epilepsy on medical treatment
Auto-immune disease, acute stage (e.g., rheumatoid arthritis)
Metastatic disease
Certain mental diseases/psychiatric conditions (e.g., schizophrenia) that would affect the subject's ability to perform all necessary study tasks
Any chronic unstable medical conditions (e.g., uncontrolled diabetes,) that may cause a subject to miss one or more of the interventions and visits
Addiction (e.g., drug/alcohol dependence) that has not been in abstinent control for at least one year
Uncontrolled systemic hypertension (historical BP \> 160/100 mmHg)
Pregnant or breast-feeding women or women that are planning to become pregnant, as this device has not been tested on pregnant women and there is no data on using rtACS for this particular group
Any severe skin condition (e.g., blisters, open wounds, cuts or irritation) or other skin defect which compromise the integrity of the skin at or near stimulation locations
IOP that the principal investigator determines that is not clinically stable
Complete blindness of both eyes
Non-resected brain tumors
Unstable diabetic retinopathy in the study eye
Optic neuropathies secondary to brain tumors
Subjects without the capacity to consent

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06662448) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Optic Neuropathy Treatment Options in New York, NY

If you're searching for optic neuropathy treatment options in New York, NY, this clinical trial (NCT06662448) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced optic neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all optic neuropathy clinical trials near you to find additional studies recruiting in your area.

More Neuropathy Trials in New York, NY

See all neuropathy clinical trials recruiting in New York — not just this study.

Browse Neuropathy Trials in New York →

Browse More Trials by Condition

Neuropathy TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY